# Assessment of Low-dose ASA Discontinuation Risk Associated With Concomitant PPI Use During the First Year of ASA Therapy

> **NCT01888575** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 35604 (actual)

## Conditions studied

- Cardiovascular Prevention

## Interventions

- **DRUG:** Risk of low dose aspirin discontinuation

## Key facts

- **NCT ID:** NCT01888575
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 35604 (ACTUAL)
- **Last updated:** 2014-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01888575

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01888575, "Assessment of Low-dose ASA Discontinuation Risk Associated With Concomitant PPI Use During the First Year of ASA Therapy". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT01888575. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*